Ana Oaknin
MD, PhD
Head of Gynecological Cancer Programme
👥Biography 个人简介
Dr. Ana Oaknin is a Spanish gynecologic oncologist who was a principal investigator in the innovaTV 204 trial of tisotumab vedotin in recurrent or metastatic cervical cancer, which led to FDA approval of tisotumab vedotin in this setting. She is an internationally recognized expert in gynecologic malignancies and novel therapeutics targeting tissue factor and other ADC targets. She contributes to ESMO gynecologic cancer guidelines.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ana Oaknin 的研究动态
Follow Ana Oaknin's research updates
留下邮箱，当我们发布与 Ana Oaknin（Vall d'Hebron University Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment